US 11939327
Heterocyclic compounds
granted A61KA61K31/4184A61K31/437
Quick answer
US patent 11939327 (Heterocyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/4184, A61K31/437, A61K31/5377, A61K31/553